This article has been cited by
1The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Li Di
Current Drug Metabolism.2019;20(2)91
[DOI]
2The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Zeng Hong-Wu,Yuan Jing,Huang Wen-Xian,Li Hong-Jun,Pu-Xuan Lu,Le Xiao-Hua,Huang Hua,Mao Xiao-Ming,Zhou Lei,Hu Ya-Nan,Wang Hao-Peng,Zhang Qian-Qian,Sha Ziling
Current Drug Metabolism.2016;20(2)57
[DOI]
3Pharmacokinetics of oseltamivir in infants under the age of 1 year
Rashmi Dixit,Slade Matthews,Gulam Khandaker,Karen Walker,Marino Festa,Robert Booy
Clinical and Translational Medicine.2016;5(1)57
[DOI]
4Psychiatric Symptoms after Taking Oseltamivir in a Child and Its Causality Assessment
Pyoungwoo Son,Joonghyuk Choi,Seungmin Lee,Seon Soon Park,Eunkyung Choi,Bong-Kyu Yoo,Eunhee Ji
Korean Journal of Clinical Pharmacy.2019;29(1)56
[DOI]
5Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?
V. C. C. Cheng,K. K. W. To,H. Tse,I. F. N. Hung,K.-Y. Yuen
Clinical Microbiology Reviews.2012;25(2)223
[DOI]
6Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: Comparison to procaine and bupropion
Akihiro Fukushima,Kaori Chazono,Yuichi Hashimoto,Yui Iwajima,Shohei Yamamoto,Yasuhiro Maeda,Masahiro Ohsawa,Hideki Ono
European Journal of Pharmacology.2015;762(2)275
[DOI]
7Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials
Sangsang Qiu,Ye Shen,Hongqiu Pan,Jianming Wang,Qun Zhang
Infectious Diseases.2015;47(11)808
[DOI]
8Hypothermic Action of Oseltamivir Not Dependent on Its Anti-influenza Virus Action
Hideki Ono
YAKUGAKU ZASSHI.2019;139(5)767
[DOI]
9Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
Mikael Boberg,Marc Vrana,Aanchal Mehrotra,Robin E. Pearce,Andrea Gaedigk,Deepak Kumar Bhatt,J. Steven Leeder,Bhagwat Prasad
Drug Metabolism and Disposition.2017;45(2)216
[DOI]
10Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases
Mario Bermúdez de León,Rafael B. R. León-Cachón,Beatriz Silva-Ramírez,Rosa Nelly González-Ríos,Brenda Escobedo-Guajardo,Roberto Leyva-Parra,Benjamín Tovar-Cisneros,Everardo González-González,Abdiel Alvarado-Díaz,Ofelia Vázquez-Monsiváis,Viviana Mata-Tijerina,Lorena Puente-Lugo,Erick Álvarez-Galván,María José Currás-Tuala,Miguel Aguado-Barrera,Fabiola Castorena-Torres,Juan Manuel Alcocer-González,Guillermo Elizondo,Ana María Salinas-Martínez
The Pharmacogenomics Journal.2020;45(2)216
[DOI]
11A prospective study of adverse drug reactions to antiepileptic drugs in children
M. Anderson,O. Egunsola,J. Cherrill,C. Millward,A. Fakis,I. Choonara
BMJ Open.2015;5(6)e008298
[DOI]
12A Lateral Flow Immunochromato-graphic Strip Test for Rapid Detection of Oseltamivir Phosphate in Egg and Chicken Meat
Xingdong Yang,Jifei Yang,Yinbiao Wang,Lili Li,Zhongke Sun,Zonghao Yue,Fengshou Tian,Le He,Xiaofei Hu
Scientific Reports.2018;8(1)e008298
[DOI]
13Reduction in Sympathetic Nerve Activity as a Possible Mechanism for the Hypothermic Effect of Oseltamivir, an Anti-influenza Virus Drug, in Normal Mice
Hideki Ono,Yui Iwajima,Yuko Nagano,Kaori Chazono,Yasuhiro Maeda,Masahiro Ohsawa,Shohei Yamamoto
Basic & Clinical Pharmacology & Toxicology.2013;113(1)25
[DOI]
14Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation
Yue Tang,Heyang Zhang,Xifeng Lu,Liqun Jiang,Xinyuan Xi,Jianping Liu,Jiabi Zhu
Drug Delivery.2015;22(5)608
[DOI]
15A prospective observational study of oseltamivir safety and tolerability in infants and young children =24?months
Barbara A. Rath,William A. Blumentals,Mary K. Miller,Kathryn Starzyk,Boguslaw Tetiurka,Martina Wollenhaupt
Pharmacoepidemiology and Drug Safety.2015;24(3)286
[DOI]
  Feedback 
  Subscribe